Volume 80, Issue 2 pp. 107-110
Free to Read

Potentiation of Invasive Capacity of Rat Ascites Hepatoma Cells by Transforming Growth Factor-β

Mutsuko Mukai

Mutsuko Mukai

Department of Tumor Biochemistry, Research Institute, The Center for Adult Diseases, Osaka, 1-3-3 Nakamichi, Higashinari-ku, Osaka 537

Search for more papers by this author
Kiyoko Shinkai

Kiyoko Shinkai

Department of Tumor Biochemistry, Research Institute, The Center for Adult Diseases, Osaka, 1-3-3 Nakamichi, Higashinari-ku, Osaka 537

Search for more papers by this author
Keiko Komatsu

Keiko Komatsu

Department of Tumor Biochemistry, Research Institute, The Center for Adult Diseases, Osaka, 1-3-3 Nakamichi, Higashinari-ku, Osaka 537

Search for more papers by this author
Hitoshi Akedo

Hitoshi Akedo

Department of Tumor Biochemistry, Research Institute, The Center for Adult Diseases, Osaka, 1-3-3 Nakamichi, Higashinari-ku, Osaka 537

Search for more papers by this author
First published: February 1989
Citations: 25

Abstract

The in vitro invasive capacity of poorly invasive cells (W1), which were cloned from rat ascites hepatoma cells (AH 130), was potentiated dose- and time-dependently by pretreating the cells with transforming growth factor-β (TGF-β). This potentiation of invasive capacity was completely abolished by anti-TGF-β antibody. When the treated cells were ip inoculated into rats, the cells extensively invaded the peritoneum, and formed penetrating tumor nodules. The effect of TGF-β was reversed by subculturing the treated cells without TGF-β. The potentiation of invasive capacity by TGF-β might participate in platelet-associated enhancement of tumor cell metastasis.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.